Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

por Bangs, Mark E., Kudrow, David, Wang, Shufang, Oakes, Tina M., Terwindt, Gisela M., Magis, Delphine, Yunes-Medina, Laura, Stauffer, Virginia L.
Publicado 2020

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

por Bangs, Mark E., Kudrow, David, Wang, Shufang, Oakes, Tina M., Terwindt, Gisela M., Magis, Delphine, Yunes-Medina, Laura, Stauffer, Virginia L.
Publicado 2020

Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

por Goadsby, Peter J, Dodick, David W, Martinez, James M, Ferguson, Margaret B, Oakes, Tina M, Zhang, Qi, Skljarevski, Vladimir, Aurora, Sheena K
Publicado 2019

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment

por Láinez, Miguel J. A., Schoenen, Jean, Stroud, Chad, Bardos, Jennifer, Bangs, Mark, Kemmer, Phebe, Wenzel, Richard, Kuruppu, Dulanji K., Martinez, James Michael, Oakes, Tina M.
Publicado 2021

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

por Martinez, James M, Ferguson, Margaret B, Pangallo, Beth A, Oakes, Tina M, Sparks, JonDavid, Dellva, Mary Anne, Zhang, Qi, Liu, Peng, Bangs, Mark, Ahl, Jonna, Goldberger, Celine
Publicado 2015